Bausch Health Companies Inc (NYSE:BHC)
| 14.60 BATS BZX Real-Time Price As of 3:00pm ET |  +1.29 / +9.69%Today’s Change | 11.15 Today|||52-Week Range 31.97 | -51.20% Year-to-Date |
Latest BHC News | Press Releases
| Bausch Health Companies: The Sell-Off Looks Overdone Apr 01 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 13.31 |
| Today’s open | 14.00 |
| Day’s range | 13.90 - 14.66 |
| Volume | 4,302,826 |
| Average volume (3 months) | 4,690,591 |
| Market cap | $4.8B |
Data as of 3:00pm ET, 04/06/2020
Growth & Valuation
| Earnings growth (last year) | +56.99% |
| Earnings growth (this year) | -1.80% |
| Earnings growth (next 5 years) | +6.30% |
| Revenue growth (last year) | +2.64% |
| P/E ratio | NM |
| Price/Sales | 1.23 |
| Price/Book | 4.50 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FTSVForty Seven Inc | +0.03 | +0.03% |
| GRFSGrifols SA | +0.03 | +0.16% |
| RGENRepligen Corp | +0.85 | +0.87% |
| RETAReata Pharmaceutical... | +6.33 | +4.91% |
Data as of 3:02pm ET, 04/06/2020
Financials
| Next reporting date | May 12, 2020 |
| EPS forecast (this quarter) | $0.90 |
| Annual revenue (last year) | $8.6B |
| Annual profit (last year) | -$1.8B |
| Net profit margin | -20.79% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Laval, Quă©bec |
Forecasts
